Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC
Clinical trial NCT04268888 · SUSPENDED
Trial details
- NCT number
- NCT04268888
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2025-08-01
- Enrollment
- 522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.